| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | (95% CI) | p Value | HR | (95% CI) | p Value | |
Age | 1.04 | (1.04–1.07) | 0.004 | 1.03 | (0.99–1.06) | 0.092 |
Sex: male | 1.11 | (0.62–2.36) | 0.58 |  |  |  |
BMI | 0.91 | (0.84–0.98) | 0.016 |  |  |  |
Malnutrition (GNRI < 92) | 3.69 | (2.11–6.42) |  < 0.001 | 2.30 | (1.13–4.67) | 0.020 |
Hypertension | 1.21 | (0.62–3.84) | 0.34 |  |  |  |
Diabetes mellitus | 1.01 | (0.59–1.78) | 0.98 |  |  |  |
Dyslipidemia | 1.48 | (0.84–2.61) | 0.174 |  |  |  |
Current smoking | 1.42 | (0.41–4.88) | 0.57 |  |  |  |
Hemodialysis | 2.63 | (1.51–4.58) |  < 0.001 | 2.17 | (1.19–3.93) | 0.011 |
Prior myocardial infarction | 1.64 | (0.73–3.64) | 0.22 |  |  |  |
Prior stroke | 3.16 | (0.43–22.9) | 0.26 |  |  |  |
Prior heart failure | 2.35 | (1.10–5.01) | 0.027 | 1.73 | (0.78–3.85) | 0.178 |
Calcium-channel blocker | 1.03 | (0.59–1.80) | 0.91 |  |  |  |
ACEI | 0.67 | (0.21–2.18) | 0.52 |  |  |  |
ARB | 0.90 | (0.63–1.30) | 0.60 |  |  |  |
β-blocker | 0.82 | (0.39–1.69) | 0.59 |  |  |  |
Statin | 0.68 | (0.38–1.20) | 0.186 |  |  |  |
Proton pump inhibitor | 1.15 | (0.59–2.25) | 0.67 |  |  |  |
Cholinesterase | 0.99 | (0.98–1.00) |  < 0.001 |  |  |  |
hs-CRP | 1.08 | (1.03–1.11) |  < 0.001 | 1.01 | (0.99–1.06) | 0.52 |
T-CHO | 1.00 | (0.98–1.00) | 0.056 |  |  |  |
LDL-C | 0.99 | (0.97–1.01) | 0.161 |  |  |  |
HDL-C | 0.98 | (0.97–1.00) | 0.28 |  |  |  |
Triglycerides | 0.99 | (0.98–1.00) | 0.073 |  |  |  |
Albumin | 0.43 | (0.28–0.65) |  < 0.001 |  |  |  |
Uric acid | 1.01 | (0.91–1.05) | 0.83 |  |  |  |
FPG | 1.00 | (0.99–1.00) | 0.61 |  |  |  |
eGFR | 0.98 | (0.97–0.99) |  < 0.001 |  |  |  |
LVEF | 0.97 | (0.96–1.00) | 0.010 |  |  |  |